menu
    • menu

    Company profile for Dynacure

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathies (CNM), a rare, debilitating disease affecting children and young adults. Dynacure’s Dyn101 development program is based on the modulation of the expression of the Dynamin 2 protein, through the use of an antisense oligonucleotide...
    Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathies (CNM), a rare, debilitating disease affecting children and young adults. Dynacure’s Dyn101 development program is based on the modulation of the expression of the Dynamin 2 protein, through the use of an antisense oligonucleotide developed in collaboration with Ionis Pharmaceuticals, the leading biopharmaceutical company in RNA-targeted drug discovery.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DynacureFrance Flag
    Country
    Country
    France
    Address
    Address
    Bioparc III 850, Boulevard Sébastien Brant F-67400 Illkirch-Graffenstaden
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dynacure.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Flamingo Therapeutics and Dynacure Announce Merger
    Flamingo Therapeutics and Dynacure Announce Merger

    02 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/flamingo-therapeutics-and-dynacure-announce-merger-to-create-leading-rna-therapeutics-company-focused-on-clinical-oncology-301760437.html

    PR NEWSWIRE
    02 Mar 2023
    Share Share
    Flamingo folds Dynacure into its flamboyance in merger deal
    Flamingo folds Dynacure into its flamboyance in merger deal

    02 Mar 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/dynacure-no-more-newly-formed-flamingo-takes-flight-after-biotech-merger

    Gabrielle Masson FIERCE BIOTECH
    02 Mar 2023
    Share Share
    Dynacure Axes Investigational Study of CNM Treatment
    Dynacure Axes Investigational Study of CNM Treatment

    09 Jul 2022

    // Vanessa Doctor BIOSPACE

    https://www.biospace.com/article/dynacure-axes-study-on-investigational-cnm-treatment/?s=61

    Vanessa Doctor BIOSPACE
    09 Jul 2022
    Share Share
    FDA grants FTD to Dynacure’s DYN101 in myotubular and centronuclear myopathies
    FDA grants FTD to Dynacure’s DYN101 in myotubular and centronuclear myopathies

    08 Jan 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=145108&sid=2

    PHARMABIZ
    08 Jan 2022
    Share Share
    Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan
    Nippon Shinyaku, Dynacure partner to develop & commercialize DYN101 in Japan

    11 Nov 2021

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143875&sid=2

    PHARMABIZ
    11 Nov 2021
    Share Share
    Dynacure Announces Strategic Collaboration and Option Agreement with Nippon
    Dynacure Announces Strategic Collaboration and Option Agreement with Nippon

    10 Nov 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/dynacure-announces-strategic-collaboration-and-option-agreement-with-nippon-shinyaku-301420762.html

    PRNEWSWIRE
    10 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search